載入...
TriKEs and BiKEs join CARs on the cancer immunotherapy highway
Unprecedented clinical success has recently been achieved in cancer immunotherapy using cytotoxic T cells armed with activating tumor-specific Chimeric Antigen Receptors (CARs). Natural killer (NK) cells, potent cytotoxic effectors, also hold potential to be effectively harnessed for immunotherapy....
Na minha lista:
| 發表在: | Hum Vaccin Immunother |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5137511/ https://ncbi.nlm.nih.gov/pubmed/27322989 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1198455 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|